Skip to main content
. 2019 May 5;20(9):2210. doi: 10.3390/ijms20092210

Figure 1.

Figure 1

Prodrugs, with the active drug covalently attached to the (a) sn-2 position of the phospholipid (PL), (b) phosphate group, or (c) the sn-1 position of the PL.